INS and diabetes mellitus: These drugs primarily exert their glucose‐lowering effects by blocking the ATP‐sensitive potassium (KATP) channels on the membrane of pancreatic β cells, stimulating insulin secretion, thereby lowering blood glucose levels and controlling the progression of diabetes [37].